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Abstract
Background: Glaucoma is the world’s second leading cause of bilateral blindness with progressive loss of vision due to
retinal ganglion cell death. Myocilin has been associated with congenital glaucoma and 2–4% of primary open angle
glaucoma (POAG) cases, but the pathogenic mechanisms remain largely unknown. Among several hypotheses, activation of
the unfolded protein response (UPR) has emerged as a possible disease mechanism.
Methodology / Principal Findings: We used a transgenic Drosophila model to analyze whole-genome transcriptional profiles
in flies that express human wild-type or mutant MYOC in their eyes. The transgenic flies display ocular fluid discharge,
reflecting ocular hypertension, and a progressive decline in their behavioral responses to light. Transcriptional analysis shows
that genes associated with the UPR, ubiquitination, and proteolysis, as well as metabolism of reactive oxygen species and
photoreceptor activity undergo altered transcriptional regulation. Following up on the results from these transcriptional
analyses, we used immunoblots to demonstrate the formation of MYOC aggregates and showed that the formation of such
aggregates leads to induction of the UPR, as evident from activation of the fluorescent UPR marker, xbp1-EGFP.
Conclusions / Significance: Our results show that aggregation of MYOC in the endoplasmic reticulum activates the UPR, an
evolutionarily conserved stress pathway that culminates in apoptosis. We infer from the Drosophila model that MYOC-
associated ocular hypertension in the human eye may result from aggregation of MYOC and induction of the UPR in
trabecular meshwork cells. This process could occur at a late age with wild-type MYOC, but might be accelerated by MYOC
mutants to account for juvenile onset glaucoma.
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Introduction
Primary open angle glaucoma (POAG, OMIM #137760) is the
most common form of the heterogeneous group of optic
neuropathies known as glaucoma [1]. POAG is generally
characterized by impeded outflow of aqueous humor from the
anterior eye chamber, resulting in elevated intraocular pressure
(IOP) and death of retinal ganglion cells [2,3].
The human glaucoma-associated myocilin (MYOC) protein has
been associated with congenital glaucoma and with a small
percentage of POAG cases [4,5]. MYOC is a 57 kDa secreted
glycoprotein of 504 amino acids encompassing two major
domains: a coil-coiled myosin-like domain near the N-terminus
and an olfactomedin-like domain (amino acids 245–504) near the
C-terminus [6,7]. Its function is unknown and the mechanisms by
which mutations in MYOC cause glaucoma are not understood.
Several lines of evidence indicate that MYOC-associated
glaucoma may be attributed to a gain-of-function disease model
such that intracellular protein accumulation leads to cellular
toxicity and cell death [8–13]. Mutant forms of MYOC that are
introduced in cultured human trabecular meshwork cells and are
not secreted accumulate as aggregates in the ER (ER) [12]. This
results in the upregulation of 78 kDa glucose-regulated protein
(GRP78) and protein disulfide isomerase (PDI), two proteins of the
UPR pathway [14]. Another study investigated secretion of 35
MYOC variants in transfected COS-7 and immortalized human
trabecular meshwork cell lines [9]. In either cell line, 20/35 of the
MYOCs were not secreted into the cell culture medium. All 20 of
these are disease-causing polypeptides in POAG and all have
mutations in the olfactomedin domain of MYOC implying that
the integrity of this domain is necessary for proper folding and that
interference of MYOC export due to mutations in the olfactome-
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proteins [9]. The solubility of MYOC complexes was also
investigated by stably co-expressing GFP-tagged wild-type or
mutant (C245Y or P370L) MYOC with transiently expressed
FLAG-tagged wild-type MYOC in CHO-K1 and HEK293 cells.
Complexes of GFP-C245Y or P370L and FLAG-tagged wild-type
MYOC that were not secreted in the culture medium formed
Triton X-100 insoluble complexes, which were retained in the
rough ER and aggregated to form inclusion bodies. These MYOC
aggregates induced the UPR proteins GRP78, PERK and
CHOP/GADD153 which results in the activation of caspases 12
and 3, and eventually elicits the apoptosis pathway [15]. These
studies suggest that accumulation of misfolded MYOC in the ER
can trigger the UPR cascade thereby compromising trabecular
meshwork cell function which would result in IOP and glaucoma.
Drosophila melanogaster has provided powerful genetic models for
several neurodegenerative diseases, including Alzheimer’s disease,
Parkinson’s disease, Huntington’s disease [17], and retinal
degeneration [16,17]. Previously, a comparative genomic ap-
proach was developed in Drosophila by overexpressing myocilin in
transgenic flies under an eye specific gmr promoter. Here, we have
used whole-genome transcriptional profiling in this model to assess
whether overexpression of wild-type and mutant forms of MYOC
in the Drosophila eye results in activation of the UPR. Indeed,
components of the UPR feature prominently among transcripts
with altered expression in the transgenic flies. To verify that
activation of the UPR is indeed correlated with the morphological
and behavioral impairments observed in the transgenic flies, we
demonstrate directly the formation of MYOC aggregates and
visualize induction of the UPR in the larval eye imaginal discs with
the ER-stress response marker, x box protein 1 (xbp1)-EGFP,
previously used to detect activation of the UPR in the Drosophila
model of retinal degeneration [16,17].
Evolutionary conservation of the UPR together with previous
reports that implicate this pathway in the etiology of glaucoma in
human trabecular meshwork cells [9,12,14] support the notion
that comparative genomics and proteomics studies that utilize the
Drosophila model may provide new insights into conserved cellular
pathways that are associated with human ocular hypertension and
glaucoma, such as identification of genetic modifiers of MYOC-
induced cellular stress.
Results
Generation of transgenic flies expressing wild-type and
mutant MYOC
We generated transgenic flies expressing wt-MYOC and mutant
MYOC in their eyes and confirmed expression of the transgenes by
quantitative RT-PCR (Figure 1). These analyses revealed greater
than 50-fold expression of MYOC in F1 flies compared to their
specific UAS-MYOC parental control (Figure 1B). The gmr-Gal4/
UAS-Q368X and gmr-Gal4/UAS-D380N hybrids had the greatest
level of expression (more than 150-fold) compared to the parental
strain. Differences in expression levels between the five MYOC
transgenic fly strains could be attributed to positional effects.
Eye phenotypes and behavioral defects in transgenic flies
Transgenic flies expressing mutant forms of MYOC developed
the same fluid discharge phenotype reported previously for flies
expressing wt-MYOC [18]. This intermittent fluid discharge
through the lenses of the compound eye could be considered a
proxy for increased intraocular pressure, which cannot be
measured directly in the Drosophila eye (Figure 2). It has previously
been shown that expression of GAL4 under the control of gmr has
an effect on Drosophila eye development. Homozygotes have a
disorganized ommatidial array and the levels of apoptosis in third-
instar larval eye imaginal discs are significantly higher compared
to wild-type discs [19]. Consistent with these results, our control
line (gmr-Gal4/Sam
w1118) displays some fluid-discharge, but this is
much less prominent than seen in the MYOC-expressing flies.
Weexaminedvisualimpairment oftheMYOCtransgenicfliesby
a behavioral assay for phototaxis using 1, 3, 6 and 8 day old flies
(Figure 3 and Table S4). As expected, Samarkand w
1118 flies were
blind and unresponsive to light (data not shown). The gmr-Gal4/
Samw
1118 control strain contains a single copy of the miniwhite gene,
and an average of 28%(18%) of the total population of 6-day old (8-
day old) control flies moved towards the light source by the end of
the 1 min trials. The gmr-Gal4/UAS-MYOC transgenic flies contain
two functional miniwhite alleles and would be expected to have better
visual function than the driver alone. The wt-MYOC and MYOC
mutants, however, showed a progressive decline in phototactic
behavior and only 5% (wt-MYOC) to 0.3% (D380N and K423E) of
8-day old flies moved towards the light source (Figure 3). To
compare differences between classes (genotype, age, and genotype x
age), we calculated pairwise contrasts and showed that mutant and
wild-type MYOC expressing flies were significantly impaired in
their phototactic behavior compared to the control at ages 3, 6 and
8-days with P-values ranging from P,0.00005 (for the D380N vs
control at age=3 days) to P=0.018 (for the R342K vs control at
age=8 days).
Transcription profiles in Drosophila eyes that express
MYOC
MYOC-induced ocular secretion with progressive deterioration
of visual function is reminiscent of the pathogenic sequelae that
lead to the manifestation of MYOC-associated glaucoma. We
hypothesized that conserved cellular pathways would be activated
in the response to cellular stress in both the transgenic MYOC
expressing flies and in compromised trabecular meshwork cells. To
identify cellular mechanisms that are recruited to respond to
overexpression of wild-type or mutant MYOC, we investigated the
genome-wide expression profiles in response to transgenic MYOC
expression and compared expression profiles of the parental UAS-
MYOC lines and the MYOC-expressing hybrids.
First, we assessed probe sets that were differentially expressed in
each gmr-Gal4/UAS-MYOC background, compared to the average
expression of the homozygous gmr-Gal4 and UAS-MYOC parental
lines (Figure 4A). Summed across all five analyses we identified
197 probe sets (corresponding to 140 non-redundant genes) at an
FDR,0.1 and in which the mean of the parental strains was
significantly different (P,0.05) from their corresponding MYOC-
expressing hybrid (Table 1 and Table S1). Ninety-seven of the 197
probe sets were upregulated (signal ratio: F1/[P1+P2]/2.1.0) and
the remaining 100 were downregulated. Of the 140 genes, 76%
were differentially regulated by one of the five different MYOC
constructs (Figure 5A). The construct that showed the greatest
disruption in genome-wide transcriptional regulation was the
truncated mutant Q368X. The altered transcription profile in flies
expressing the Q368X mutation showed the least overlap with
those of flies expressing wt-MYOC or the R342K, D380N and
K423E mutants (Figure 5A). Genes that showed altered expression
when this construct was overexpressed; include turtle, RpS24, Bruce,
Osi6 and Obp57a. To account for the possibility that gene
disruption in any one construct might be due to positional effects
of the insertion of the construct rather than the presence of the
transgene, we focused on genes that were differentially regulated in
three or more of the five transgenic constructs. Only 18 genes
fulfilled this criterion. Five of these genes (CG8613, Cyp6g1, Glut1,
Myocilin-Associated Glaucoma
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CYP3A7, SLC2A1, SAT2, and SKP2 respectively). Overrepre-
sented molecular function categories include eye pigment
precursor transporter activity, permease activity, photoreceptor
activity and receptor binding (Figure 5B).
Our initial analysis identified probe sets that are differentially
expressed in each MYOC background, but is limited in power since
each analysis is based on only nine arrays. We performed a second
analysis which simultaneously compares gene expression levels of all
five MYOC transgenes as homozygotes and as F1 gmr-Gal4/UAS-
MYOCheterozygotes. Thisanalysisconsidersexpression ofMYOC to
be ‘off’ in the homozygous MYOC genotypes and ‘on’ in the
heterozygous genotypes (Figure 4B). Using this approach we detected
a total of 8063 probe-sets (5511 non-redundant probe-sets) with
significant variation in transcript abundance (FDR,0.001; Table 1
and Table S2). Of these genes, 2643 genes (33%) were significantly
different by expression, in other words, whether the expression of
MYOC when turned ‘‘off’’ (parental P2 lines) is significantly different
from when it is turned ‘‘on’’ via the gmr promoter (F1 hybrids). Fold
level changes (Table S3) were estimated by calculating the signal ratio
of F1/P2. This resulted in 2,118 genes that were up-regulated (signal
ratio, F1/P2.1.00) and 525 genes that were down-regulated (signal
ratio, F1/P2,1.00). Of the 2,643 genes that were significantly
different by expression, 44% have human homologs. These included
the five genes with human orthologs identified in the previous
analysis, described above (FDR,0.001).
We identified molecular function gene ontology categories that
were enriched for each of the three terms of this two-way ANOVA
(Figure 6). These categories include peptidase activity, photorecep-
tor activity, signal-sequence binding, oxidoreductase activities,
transferase activity, heat shock protein binding, ubiquitin conjugat-
ing enzyme activity, unfolded protein binding, ATPase activities,
SNAP receptor activity and ligase activity. Genes which encode
peptidases include Prosbeta2, Prosbeta3, Prosbeta5, Prosalpha7, Pros25,
Pros26, Pros29 and Pros54, all of which are proteasome components
and were upregulated. Ubiquitin conjugating enzyme activity and
unfolded protein binding were especially prominent molecular
function GO categories, which were significantly enriched accord-
ing to all three terms of the two-way ANOVA. Drosophila genes
within the ubiquitin enzyme activity categories include Bruce,
UbcD2, UbcD4, UbcD6, UbcD10, Uba1, and Uev1A with human
orthologs BIRC6, UBE2E1, HIP2, UBE2A, UBE2L3, UBE1 and
UBE2V1, respectively. The unfolded protein binding category
includes the Drosophila genes PEK, Hop, Hsc70-5, Gp93, CG7598 and
Crc with human homologues EIF2AK3, STIP1, HSPA9B,
HSP90B1, NDUFAF1, and CALR, respectively.
Figure 1. Expression of wt-MYOC and mutant MYOCs in transgenic flies. A) Diagram of the MYOC polypeptide showing the position of the
amino acid substitutions (R342K, Q368X, D380N and K423E) that were created by site-directed mutagenesis. The Q368X mutant is predicted to result
in a premature stop codon (octagon). Also shown are the N-terminal myosin-like domain and the C-terminal olfactomedin domain. B) Gene
expression by quantitative PCR of human wt- MYOC and mutant MYOCs in heads of transgenic flies. Expression of MYOC is evident where the Gal4
driver is combined with the UAS-transgenes, but not in the parental lines.
doi:10.1371/journal.pone.0004216.g001
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The induction of transcripts that encode components of the
UPR and ubiquitination pathways suggested that aggregation of
wt-MYOC and MYOC mutants might result in an ER stress
response, which induces the UPR, as may occur in the human
trabecular meshwork [12]. We used a MYOC antibody and
Western blotting to identify the expressed proteins in homogenates
from transgenic fly heads. Polyacrylamide gel electrophoresis and
immunoblotting confirmed the presence of an immunoreactive
protein of correct molecular weight of approximately 57 kDa
(Figure 7) for wt-MYOC, as well as for the D380N, K423E, and
R342K mutants. As expected, the Q368X MYOC mutant results
in the translation of a truncated protein of about 41 kDa due to
the presence of a premature stop codon at amino acid position 368
(Figure 7). To confirm the presence of MYOC aggregates in the
transgenic flies, we fractionated homogenates from fly heads into
soluble and insoluble fractions. The majority of wt-MYOC and
the R342K, D380N and K423E MYOC mutants were recovered
in the insoluble fraction, indicating extensive aggregation
(Figure 7). We observed fewer aggregates of the Q368X protein,
which lacks the C-terminal olfactomedin domain and was
recovered mainly in the soluble fraction. In addition, we observed
smaller molecular-weight soluble and insoluble immunoreactive
polypeptides for the D380N construct, indicating that this protein
may be unstable and undergoing degradation. No immunoreactive
MYOC polypeptides were seen in the gmr-GAL4 control. The
Drosophila genome encodes a single olfactomedin-like protein
(CG6867), which is expressed in the antenna and ocelli, but not
Figure 2. Eye phenotypes and phototactic responses of wild-type and mutant MYOC transgenic flies. Fluid discharge from eyes of
transgenic flies. The normal appearance of eyes from a fly of the gmr-Gal4/Sam
w1118 control line is shown in panel A. A fly eye expressing the wt-
MYOC with liquid discharge (white arrow) is shown in panel B. The flies expressing mutant MYOCs displaying a white salt residue (black arrows) after
drying of the liquid residue (panels C–F).
doi:10.1371/journal.pone.0004216.g002
Figure 3. Phototactic behavior of MYOC-expressing transgenic flies. Progressive visual impairment of the MYOC-expressing flies compared
to the gmr-Gal4/Sam
w1118 control line is observed.
doi:10.1371/journal.pone.0004216.g003
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react with our MYOC antibody. The high molecular weight band
(.200 kDa) that is evident in the insoluble lanes likely corresponds
to the Drosophila myosin heavy chain (CG31045, ,240 kDa),
which is homologous to the N-terminal (amino acids 74–176) of
human MYOC [20].
The UPR is activated in response to overexpression of
MYOC
To confirm activation of the UPR, we used a specific UPR
marker, xbp1-EGFP, in which EGFP is expressed upon ER-stress
in response to proteins that form aggregates in the ER [16]. We
generated double-heterozygous transgenic flies that harbor the
xbp1-EGFP marker and express the wt-MYOC and each of the
four mutants (R342K, Q368X, D380N and K423E) using the gmr-
Gal4/UAS system [21]. We also generated a line that expresses
neuropathy target esterase (NTE) as a negative control. NTE is the
human ortholog of swiss cheese, which is upregulated in flies that
overexpress MYOC [18]. We did not observe activation of the
UPR either in control flies or in NTE expressing flies, indicating
that upregulation of NTE is a consequence rather than a cause of
the MYOC-induced UPR (Figure 8). Activation of the xbp1-EGFP
construct showed prominent punctate nuclear fluorescent staining
in the larval eye-imaginal discs of flies expressing MYOC,
especially those expressing the Q368X and D380N MYOC
mutants (Figure 8), which show the highest expression levels in the
transgenic flies (Figure 1B). Thus, MYOC aggregate formation
appears to induce the UPR.
Discussion
Drosophila as a disease model
Drosophila melanogaster has emerged as a surprisingly powerful
genetic model system for the study of quintessential human
disorders such as Alzheimer’s disease [22], Parkinson’s disease
[23,24], Huntington’s disease [25] and retinal degeneration [16].
Comparative genomic approaches using mutant or transgenic flies
have been applied to investigate disease mechanisms under
conditions in which both the genetic background and environ-
mental conditions can be controlled.
MYOC is one of few genes that have been linked to the
incidence of glaucoma [5,26–30]. The Q368X mutation is
predicted to result in a truncated MYOC-protein and was
identified in two families during a screen of four different
chromosome 1q-linked glaucoma families [30] and in 3/103
Figure 4. Diagrammatic representation of the expression microarray analysis. A) One-way ANOVA was used to compare differences
between expression levels for each probe set in the F1 hybrid and the expected mean value of the two parents according to the model Y=m+G+e,
where m is the overall mean, G is the effect of genotype, and e is the error variance. B) Two-way ANOVA was used to compare differences between
expression levels for each probe set between F1 hybrids in which the UAS-transgene was ‘on’ or ‘off’ according to the model Y=m+E+C+E6C+e,
where E represents the effect of MYOC expression (‘on’ or ‘off’), C is the effect of the MYOC construct (wt-MYOC, R342K, Q368X, D380N, K423E), E6C is
the effect due to the interaction between expression and each construct, and e is the error variance.
doi:10.1371/journal.pone.0004216.g004
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patients from five different populations representing three racial
groups identified Q368X as the most common mutation,
occurring in 1.6% of the probands, except among Japanese [31].
The D380N and R342K mutations were each detected in 2/90
West African POAG patients but not in 76 ethnically matched
controls [32]. A French-Canadian family has been described in
which both parents had glaucoma due to heterozygosity for the
K423E mutation of the MYOC gene [33]. Like MYOC-associated
glaucoma in humans (in particular juvenile onset), the fluid
discharge phenotype observed in the transgenic flies that
overexpress intact or mutant MYOC is likely to result from
ocular hypertension and causes a rapid and progressive deterio-
ration of visual function.
Glaucoma and the UPR
Previous studies in cultured human trabecular meshwork cells
have suggested that the UPR in response to aggregation of MYOC
would represent one disease mechanism in the pathogenesis of
intraocular pressure and glaucoma [13,15].
The UPR signaling pathway is activated by ER stress leading to
increased transcription of gene products which reduce the overall
rate of protein translation while increasing the degradation of
misfolded ER proteins through the ubiquitin-proteasome pathway.
When these adaptive responses are not sufficient to relieve ER
stress, apoptosis is induced [34]. Using transcription profiling in
transgenic flies that express wt-MYOC and mutants of MYOC we
Figure 5. Probe sets with altered transcript abundance when expression in the F1 is compared to the predicted mean values of the
parents. A) Venn diagram [64] depicting the overlap of probe sets among MYOC transgenes. Only one gene (1632731_at; CG8613) was differentially
expressed in flies carrying the K423E construct and is not included in the diagram. The Q368X construct shows a uniquely high proportion of
transcripts with altered expression (89%) that do not overlap with transcripts with altered expression in the other transgenic lines. B) Bar-chart
showing the distribution of differentially expressed genes among Gene Ontology (GO) molecular function processes according to the analysis
illustrated in Figure 4A. Parameters in DAVID [62] were set to GO level ‘‘all’’, count threshold of 2 and EASE threshold of 0.1. The output is sorted by
percentage. Asterisks refer to modified Fisher-Exact P values (P,0.05, i.e. strongly enriched in the annotation categories) and the numbers in brackets
refer to the number of genes in the category.
doi:10.1371/journal.pone.0004216.g005
Table 1. Differential regulation of gene expression in eyes of
transgenic flies that express wt-MYOC or mutant MYOCs,
detected by one-way and two-way ANOVA*.
Number of Genes with Altered Transcriptional Regulation
One-Way ANOVA Two-Way ANOVA
FDR F1 vs Parental mean Expression Construct E6C
0.1 140 (non-redundant) 7054 8272 8355
0.01 8 4673 6156 6111
0.001 0 2643 3117 2301
0.0001 0 1065 162 90
0.00001 0 482 19 4
*A diagrammatic representation of the analyses is shown in Figure 4.
doi:10.1371/journal.pone.0004216.t001
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PLoS ONE | www.plosone.org 7 January 2009 | Volume 4 | Issue 1 | e4216Figure 7. Western blot of soluble (S) and insoluble MYOC proteins (I) isolated from heads of transgenic flies. The wt-MYOC, R342K,
Q368X and K423E represent the corresponding gmr-Gal4/UAS-MYOC genotypes; gmr-Gal4 designates the gmr-Gal4/Sam
w1118 control. The solid-arrow
indicates the MYOC proteins that are expressed in the gmr-GAL4/UAS-MYOC heads at ,57 kDa. The dashed-arrow indicates the Q368X-MYOC protein
at ,41 kDa. MYOC proteins recovered in the insoluble fraction represent aggregated proteins prior to treatment with SDS. The high molecular
weight band that is also observed in the gmr-Gal4/Sam
w1118 control, likely represents cross-reactivity with the myosin heavy chain (arrow-head).
doi:10.1371/journal.pone.0004216.g007
Figure 8. ER-stress activates xbp1-EGFP expression in MYOC-expressing transgenic flies. All panels show eye-imaginal discs from third-
instar F1 larvae after crossing gmr-Gal4/UAS-xbp1-EGFP flies to the following lines: A) gmr-Gal4/Sam
w1118 (control), B) gmr-Gal4/UAS-NTE,C )Gal4/UAS-
Q368X,D )gmr-Gal4/UAS-D380N. Panels C9 and D9 show 1006magnifications of the boxed areas in C and D, respectively. Punctate nuclear staining
reflects activation of the UPR. Only background fluorescence is observed in flies that overexpress NTE (B) without the characteristic punctate nuclear
staining.
doi:10.1371/journal.pone.0004216.g008
Figure 6. Gene ontology categories when transcript expression is analyzed across all genotypes comparing the ‘on’ and ‘off’ mode
(Figure 4B). Bar-chart showing the distribution of differentially expressed genes among Gene Ontology (GO) molecular function processes, for each
of the 3 terms in the two-way ANOVA (expression, A; construct, B; expression6construct, C). Parameters in DAVID [62] were set to GO level 3, count
threshold of 2 and EASE threshold of 0.1. The output is sorted by percentage. Asterisks refer to modified Fisher-Exact P-values (P,0.05, i.e. strongly
enriched in the annotation categories) and the numbers in brackets refer to the number of genes in the category.
doi:10.1371/journal.pone.0004216.g006
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apoptosis, and oxidative stress characteristic of pathways that can
be triggered by ER stress as a consequence of misfolded protein
accumulation [35]. The transcription profile data together with
the detection of insoluble MYOC on Western blots suggests a
mechanism by which misfolded MYOC accumulates in the ER,
resulting in a cellular stress response that triggers a cascade of
events which leads to the degradation of misfolded proteins via the
ubiquitin-proteasome pathway. We visualized the ER-stress
response directly with a UPR-specific marker, xbp1-EGFP, and
observed expression of EGFP in the MYOC and mutant MYOC-
expressing lines, but not in control flies (gmr-Gal4/UAS-xbp1-EGFP)
or NTE-expressing flies. This indicates that the UPR pathway is
indeed activated specifically by MYOC aggregates. Activation of
the UPR was observed also in flies that express the Q368X mutant
(Figure 8), even though less aggregation was observed in these
transgenic flies (Figure 7). This is mostly likely due to the formation
of weak aggregates which dissociate upon detergent solubilization
and SDS-PAGE, since the truncated Q368X protein lacks the
olfactomedin presumptive protein-protein interaction domain. It is
also possible that accumulation of the Q368X protein leads to the
UPR via a different mechanism, since it cannot be processed
through the ER; previous studies have shown that truncated forms
of MYOC are not secreted in the trabecular meshwork [8].
The misfolded protein aggregation hypothesis in the etiology of
glaucoma is attractive as it places this disease in the same category
of other neurodegenerative diseases that are associated with the
formation of protein aggregates, including Huntington’s disease,
and Alzheimer’s disease, which are also diseases that become
manifest at an advanced age, like glaucoma. It should be noted
that the normal function of MYOC may not be related to its
pathogenic role in the trabecular meshwork. Neuronal olfactome-
dins have been implicated in early development of the nervous
system [36,37]. Thus, one can speculate that MYOC, a member of
the olfactomedin family, may have a function primarily in early
eye development, and that its expression in the adult eye is
recapitulated only under conditions of stress.
Our studies show evidence that the wild-type and mutant
MYOCs cause ocular fluid discharge, MYOC aggregation, and
induction of the UPR and that these effects correlate with the
magnitude of MYOC expression (Figures 1B, 7 and 8). This is
consistent with previous evidence from animal models, including
studies in rats [38] and glaucomatous dogs [39,40] in which an
increased level of MYOC is associated with increased intraocular
pressure and severity of the disease. In addition, our results are
consistent with studies in cultured human trabecular meshwork
cells, which have proposed a cellular stress response as a possible
mechanism in the pathogenesis of glaucoma [12,13,15,41]. Studies
in mice, however, have been equivocal in this regard. When a
mouse MYOC Y423H mutant (analogous to the human Y437H
MYOC allele) was introduced into the endogenous mouse MYOC
locus, the Y423H mutant MYOC protein was not secreted into
the aqueous humor, but accumulated in cells of the iridocorneal
angle [42]. These mice, however, showed no evidence of ER
stress, ocular hypertension or glaucoma at 18 months of age.
However, intraocular pressure and/or the UPR pathway might
have been detected eventually if the mice had been allowed to age
longer. Other transgenic mice in which an Y423H MYOC mutant
transgene was introduced displayed symptoms of glaucoma
including elevated intraocular pressure and loss of retinal ganglion
cells [43]. In these mice mutant Y423H MYOC formed complexes
with wt-MYOC which prevented its secretion. A third study also
showed that mice expressing mutant human MYOC (including
Q368X and Y437H) in their eyes developed elevated intraocular
pressure [44]. This study proposed that the observed intraocular
pressure was due to the exposure of a cryptic C-terminal
peroxisomal targeting signal type 1 receptor (PTS1R) site on the
misfolded mutant MYOC molecule. Indeed, the Drosophila
homolog of PTS1R, CG14815, is differentially expressed in our
transgenic Drosophila model.
Alternative pathogenic mechanisms
Is the UPR the only pathogenic mechanism involved in the
induction of ocular hypertension? Oxidative stress may contribute
to the pathogenesis of several neurodegenerative diseases, including
glaucoma(forreviewssee[45,46]).Oxidativestressoccursasaresult
of excessive production of reactive oxygen species which over-
whelms the antioxidant capacity of the cell and leads to damage of
nucleicacids, proteins and lipids. Oxidoreductaseactivities emerged
as enriched molecular function categories in the analysis of our
transcription profiles (Figure 6). Under normal conditions, reactive
oxygen species are removed by superoxide dismutase, glutathione
peroxidase and catalase. All three enzymes were up-regulated at
FDR,0.001 (Table S3). In addition, we identified 31 cytochrome
P450s (including Cyp6g1, Cyp6a23, Cyp12b2), 25 of which were up-
regulated. Mutations in CYP1B1 have been identified in numerous
studies of congenital glaucoma [47–53].
Conclusions
Targeted expression of human glaucoma-associated MYOC in
the Drosophila eye results in a fluid extrusion phenotype reminiscent
of ocular hypertension accompanied by visual behavioral impair-
ments. Whole-genome transcriptional analysis identifies changes in
transcript abundance in conserved cellular stress pathways,
including the unfolded protein ER stress response. Immunoblot-
ting reveals MYOC aggregates and activation of the UPR is
demonstrated directly with a fluorescent reporter transgene.
Comparative genomics studies using the fly model may provide
insights into conserved cellular pathways that are associated with
the etiology of human ocular hypertension and glaucoma.
Materials and Methods
Cloning of MYOC mutants
Four MYOC mutants were generated by site-directed mutagen-
esis using the QuickChange mutagenesis kit (Stratagene, La Jolla,
CA) according to the manufacturer’s protocol. The template used
was the pMC2vector [8]which is the human wild-type MYOC (wt-
MYOC) cDNA cloned into the pCR2.1 vector (Invitrogen,
Carlsbad, CA). The following primer pairs were used to generate
the MYOC variants: R342K (59-ccagggcgctgagtccaAaactgtcataa-




tccgtgtagccacccc); and K423E (59-gggagacaaacatccgtGagcagt-
cagtcgcc and 59-ggcgactgactgctCacggatgtttgtctccc). The capital
letter in each primer denotes the base-pair that was mutated in
order to generate the MYOC variant encoding the amino-acid
substitution.
Each MYOC construct was excised from the pCR2.1 vector
and cloned into the KpnI and NotI sites of the pUAST
transformation vector. The sequences of the cloned inserts were
confirmed and the MYOC constructs were designated pUAST-wt-
MYOC, pUAST-R342K, pUAST-Q368X, pUAST-D380N and
pUAST-K423E. P-element transformation was performed accord-
ing to standard procedures [54] in the Samarkand w
1118 strain
(Sam
w1118) by the Model Systems Genomics group (Duke
Myocilin-Associated Glaucoma
PLoS ONE | www.plosone.org 9 January 2009 | Volume 4 | Issue 1 | e4216University, Durham, NC), as previously described [18]. To
determine in which chromosome the P-element had inserted,
crosses of homozygous pUAST-MYOC males to virgin-female
double-balancer stocks (w; CyO/Sp; TM3, Sb/H) were carried out
[55]. The resulting F1 or F2 hybrids revealed that the wt-MYOC
and Q368X-MYOC transgenes were inserted into chromosome 2
while the other constructs (R342K, D380N, and K423E) were
inserted into chromosome 3.
Male flies carrying the gmr-Gal4 driver (P{GAL4-ninaE.GMR}12,
FlyBase ID FBti0002994) were obtained from the Drosophila stock
center (Bloomington, IN). We assessed phenotypic effects of 11
genotypes: gmr-Gal4, UAS-wtMYOC,U AS-R342K, UAS- D380N,
UAS-K423E, UAS-Q368X, and the five gmr-Gal4/UAS-MYOC
heterozygous F1 hybrids in which MYOC is expressed in the eyes
[18].TheF1hybridsweregeneratedbycrossinggmr-Gal4 males(P1)
to Sam
w1118/pUAST-MYOC virgin females (P2). In addition we
generated flies that overexpress NTE under a UAS promoter.
Expression was verified by RT-PCR. All flies were maintained at
25uC and 70% humidity, on a 12-hour light-dark cycle.
Real-time Quantitative PCR
Total RNA from the same batch used for transcription profiling
was treated with Dnase1(Invitrogen) and converted to cDNA with
the High Capacity cDNA Archive Kit and random primers
(Applied Biosystems, Foster City, CA), using 125 ng total RNA per
100 ml reaction for each sample. Each pre-formulated TaqMan
Gene Expression Assay (Applied Biosystems) consists of two
sequence-specific PCR primers and a TaqMan assay-FAM labeled
MGB (minor groove binder) probe. Each TaqMan assay was
performed in quadruplicate for each cDNA sample. Each replicate
assay used 11.25 ng total cDNA in a 20 ml final volume. Assays
were run with 26 Universal Master Mix without uracil-N-
glycosylase (Applied Biosystems) on Applied Biosystems 7900 Fast
Real-Time PCR System using universal cycling conditions
(10 min at 95uC; 15 s at 95uC and 1 minute at 60uC, 40 cycles).
The pre-formulated TaqMan assay (Applied Biosystems) for
human MYOC (assay ID: Hs00165345_ml) was used. The
Drosophila GAPDH TaqMan gene expression assay was used as
the endogenous control (assay ID: Dm01841185_m1).
Data were normalized by subtracting the average CT (threshold
cycle) of GAPDH from each replicate to give the DCT. The
expression level of each sample was calculated as 2
(2DCT6SD),
where SD is the standard deviation.
Phototaxis Response
Visual impairments among transgenic fly genotypes were
quantified using a phototaxis assay. Behavioral assays for
phototaxis were performed in the dark using a protocol similar
to ones described previously [56,57]. An 186150 mm Pyrex test
tube was wrapped with black electrical tape and joined by a
rubber ring to a clear 186150 mm Pyrex test tube. A halogen
lamp (12 V, 20 W) was used as the light source and was placed at
a height of 12 inches perpendicular to the tubes. Flies were dark-
adapted for 10 minutes and then gently tapped into the dark-side
of the double-tube. The double-tube was placed horizontal at table
level and the halogen light was turned on. Flies were given
1 minute to move from the dark tube towards the light, and the
number of flies that migrated towards the light was recorded.
Three trials each were performed on each of two replicates with
mixed male-female populations of 50 flies, aged 1, 3, 6 and 8 days.
Data were analyzed by ANOVA, using PROC MIXED
implemented in SAS 9.13 statistical software (Cary, NC),
according to the model, Y=m+G+A+G6A+R(G6A)+T(R)+e,
where Y is the observed value, m designates the overall mean, G
,A, R and T denote genotype, age, replicate, and trial, respectively,
and e is the residual experimental error. The R(G6A) and T(R)
terms were used as random effects in the model.
Transcriptional profiling
RNA was extracted from 3 independent biological replicates per
genotype with Trizolreagent(Invitrogen,Carlsbad,CA)fromheads
of adult flies harvested 3–5 days post-eclosion, reared under
controlled conditions of temperature (25uC), humidity (70%) and
light cycle (12 hr/ 12 hr) and deprived of food for 20 minutes prior
to RNA extraction. Transcriptional profiles for all 11 genotypes
were generated simultaneously for a total of 33 GeneChips.
Biotinylated cRNA probes were prepared by one-cycle target
labeling, hybridized to high-density oligonucleotide microarrays
(Drosophila 2.0 genome arrays; Affymetrix, Inc., Santa Clara, CA)
and visualized with a streptavidin-phycoerythrin conjugate as
described in the Affymetrix GeneChip Expression Analysis 2000
technical manual, using internal references for quantification.
Microarray data preprocessing
Expression data were extracted from the .cel files using the Affy
package in R-bioconductor [58]. All arrays were quantile
normalized to remove non-biological variation between arrays
using the Robust Multi-chip Averaging (RMA) algorithm [59]. We
analyzed the log2 signal intensities of the perfect match probes
(PM data). We used the Microarray Suite (MAS) 5.0 [60] present/
absent calls as a noise filter (absent in more than three samples
with signal intensities less than 4.906) to remove absent and low
hybridization features. The correlation between replicates was
high, ranging from 0.9971 to 0.913 with a median of 0.987. The
raw microarray data are deposited in the ArrayExpress database
(http://www.ebi.ac.uk/microarray-as/ae/) under accession num-
ber E-MEXP-1179.
Statistical analysis: detection of differentially expressed
genes
We performed two statistical analyses to identify differentially
expressed genes in the MYOC backgrounds. First, we compared
expression levels of the gmr-Gal4 and UAS-MYOC homozygous
parental genotypes with that of the gmr-Gal4/UAS-MYOC F1
hybrids separately for each MYOC genotype. We performed one-
way ANOVA for each probe set according to the model Y=m+G+e,
where m is the overall mean, G is the fixed effectof genotype, and e is
the error variance. All genes for which the effect of genotype was
significant at a false discovery rate (FDR; [61]) of ,0.1 were further
tested to determine whether mean expression of the F1 hybrid was
significantly different from the average of the two parental strains
(P,0.05;[18]). This analysis identifies probe sets that are differen-
tially expressed in each MYOC background, but is limited in power
since each analysis is based on only nine arrays.
The second analysis simultaneously compared gene expression
levels of all five MYOC transgenes as homozygotes and as F1 gmr-
Gal4/UAS-MYOC heterozygotes. ExpressionofMYOCis ‘off’ inthe
homozygous MYOC genotypes and ‘on’ in the heterozygous
genotypes. We analyzed these data by two-way ANOVA for each
probe set according to the model Y=m+E+C+E6C+e, where E
represents the effect of MYOC expression (‘on’ or ‘off’), C is the
effect of the MYOC construct (wt-MYOC, R342K, Q368X,
D380N, K423E), E6C is the effect due to the interaction between
expression and each construct, and e is the error variance. All effects
were fixed. We analyzed probe sets that were significant for the
main and interaction effects at FDR,0.001. Statistical analyses
were implemented using SAS 9.13 software (Cary, NC).
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DAVID [62] which can be accessed at http://david.abcc.ncifcrf.
gov/, the NetAffx Analysis Center (http://www.affymetrix.com/
analysis/index.affx) and FlyBase (http://www.flybase.org, release
4.3).
Western Blotting
Analysis of MYOC protein aggregates formed by wt-MYOC
and mutant MYOC in the transgenic flies were examined by
Western blotting from a homogenate of 10 fly heads by extracting
both soluble and insoluble proteins, as described previously [8].
Briefly, ten heads from five-day old flies were homogenized with
100 ml of ice-cold extraction buffer (10 mM Tris-HCl, pH 7.5,
5 mM EDTA, 1% NP-40, 0.5% deoxycholate, 150 mM NaCl)
containing 1% protease inhibitor cocktail (Sigma-Aldrich) and
lysed for 30 minutes at 4uC. The samples were centrifuged at
13,000 rpm for 15 minutes at 4uC. The supernatants were
collected and the insoluble pellets solubilized with 50 mlo f
10 mM Tris-HCl, 1% SDS for 10 minutes at room temperature
and the volume adjusted to 100 ml with extraction buffer. Laemmli
sample buffer (Bio-Rad Laboratories, Hercules, CA) containing
5% b-mercaptoethanol (Sigma-Aldrich, St. Louis, MO) was added
to the cell extracts and the samples were boiled for 10 min. The
samples were centrifuged at 13,000 rpm for 10 min at 4uC and
equal volumes of the supernatants were separated by 7.5% SDS-
PAGE, transferred to 0.45 micron nitrocellulose membranes, and
probed with a 1000-fold dilution of anti-human MYOC antibody
(R&D systems, Minneapolis, MN). Bound antibody was visualized
with an 8000-fold dilution of anti-goat IgG-alkaline phosphatase
(Sigma-Aldrich) secondary antibody and visualized using nitroblue
tetrazolium chloride/ 5-bromo-4-chloro-39-indoylphosphate p-
toluidine salt as the chromogenic substrate (Sigma-Aldrich).
Immunohistochemistry
To visualize the ER-stress response in the MYOC-expressing
flies, we crossed gmr-Gal4-UAS-MYOC lines with the gmr-Gal4-UAS-
Xbp1-EGFP line to assess activation of the xbp1-EGFP marker
[16]. Xbp1 is a component of the UPR pathway and splicing of
the xbp1 mRNA at the Ire-1 splice site upon activation of this
pathway enables the expression of EGFP [16]. We dissected brains
from third instar larvae and immunostained them as described
previously [63] using rabbit anti-GFP (Invitrogen Molecular
Probes) as the primary antibody (1:250 dilution) followed by
FITC-conjugated Goat anti-Rabbit secondary antibody (1:500
dilution) (Jackson ImmunoResearch Laboratories, Inc.). After the
brains were stained, we dissected the eye-imaginal discs and
viewed them using a Zeiss Axioplan fluorescent microscope with
digital image collection.
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